Spectralis SLO Heidelberg: Advanced Retinal Imaging
Understanding the Spectralis SLO Heidelberg
The Spectralis is a confocal scanning laser ophthalmoscope (a device that uses focused laser light to create detailed images of the retina). Heidelberg Engineering introduced it in 2006. It was the first imaging platform to combine scanning laser ophthalmoscopy with spectral domain optical coherence tomography, commonly called SD-OCT. SD-OCT uses light waves to capture cross-sectional images of the retina. This works similarly to how ultrasound uses sound waves to image other parts of the body.
The Spectralis is not a treatment. It is a diagnostic tool that captures high-resolution images of the structures at the back of your eye. These images help your retina specialist detect disease, measure changes over time, and make informed decisions about your care.
The Spectralis uses dual-beam technology. One beam captures a live image of the retina surface while a second beam takes cross-sectional scans beneath the surface. A patented feature called TruTrack Active Eye Tracking continuously adjusts for natural eye movement during the scan. The system locks onto a specific point on your retina and repositions the scanning beam whenever your eye shifts.
Another feature, called Heidelberg Noise Reduction, merges multiple scans taken at the same retinal location. This process removes unwanted visual noise and produces images of exceptional clarity. Together, these features make the Spectralis one of the most precise retinal imaging systems available.
The Spectralis platform offers six different imaging modalities in a single system. Each modality reveals different information about the health of your retina.
- Spectral-Domain OCT: Creates detailed cross-sectional images of retinal layers.
- Fluorescein Angiography: Uses a special dye injected into a vein to highlight blood vessel patterns and leakage in the retina.
- ICG Angiography (indocyanine green angiography): Uses a different dye to image deeper blood vessels beneath the retina.
- Autofluorescence: Detects naturally occurring fluorescent signals from the retinal pigment epithelium, a layer beneath the retina.
- Infrared Imaging: Captures images using infrared light, which penetrates deeper retinal structures.
- Red-Free Imaging: Uses green light to enhance the contrast of blood vessels and other retinal features.
Why This Imaging Matters for Your Eyes
The Spectralis helps retina specialists detect changes in the retina before symptoms become noticeable. This is important because many retinal conditions cause irreversible damage if not caught early. An estimated 18.34 million individuals aged 40 and older in the United States had early-stage age-related macular degeneration as of 2019. Another 1.49 million had late-stage disease (NEI, 2022). Early detection through advanced imaging allows treatment to begin sooner, which can help preserve remaining vision.
Because the TruTrack system locks onto the exact same retinal location each visit, the Spectralis produces highly reproducible scans. Your retina specialist can compare images taken months or years apart with great accuracy. Even small changes in retinal thickness, fluid accumulation, or tissue loss can be measured. This precision is essential for tracking conditions like diabetic macular edema, wet age-related macular degeneration, and retinal vein occlusion.
The detailed images from the Spectralis help your retina specialist decide when to start treatment, adjust treatment, or determine that a condition is stable. For patients receiving intravitreal injections (injections of medication into the eye) for conditions like wet macular degeneration, OCT imaging is used at nearly every visit. The specialist checks for fluid under or within the retina. The imaging results directly influence whether an injection is needed or can be safely delayed.
Conditions Diagnosed and Monitored
Age-related macular degeneration, or AMD, is one of the leading causes of vision loss in older adults. The prevalence of AMD among adults aged 65 and older in the United States is approximately 10.4% (NHANES, 2025). Higher rates are observed in the oldest age groups, females, and White individuals. The Spectralis can detect early drusen deposits, monitor geographic atrophy in dry AMD, and identify fluid leakage associated with wet AMD. Autofluorescence imaging is particularly useful for mapping areas of geographic atrophy over time.
People with diabetes are at risk for diabetic retinopathy, a condition where high blood sugar damages blood vessels in the retina. The Spectralis can reveal swelling in the macula (the central part of the retina responsible for sharp vision), leaking blood vessels, and areas of poor blood flow. These findings help your retina specialist determine whether laser treatment, intravitreal injections, or close monitoring is the right approach.
While glaucoma is often managed by glaucoma specialists, the Spectralis plays a role in measuring the thickness of the retinal nerve fiber layer and the ganglion cell layer. Thinning in these layers can signal glaucoma damage. The Glaucoma Module Premium Edition provides comprehensive analysis of the optic nerve head, retinal nerve fiber layer, and macular ganglion cell layer.
The Spectralis helps identify blocked retinal veins and the resulting swelling, bleeding, or poor blood flow. Fluorescein angiography and OCT angiography are especially useful for mapping areas of the retina that are not getting enough blood supply. These findings guide decisions about treatment with anti-VEGF injections or laser therapy.
What to Expect During Your Scan
Your retina specialist may dilate your pupils with eye drops before the scan. Dilation allows the imaging system to capture a wider and clearer view of the retina. The drops take about 15 to 30 minutes to fully work. Your vision will be blurry and sensitive to light for several hours after dilation, so you may want to arrange a ride home.
If fluorescein angiography or ICG angiography is planned, a small amount of dye will be injected into a vein in your arm. The dye travels through your bloodstream to the blood vessels in your eye. The Spectralis camera then captures images of how the dye flows and whether any vessels are leaking.
You will sit in front of the Spectralis device and rest your chin on a support. The technician will ask you to look at a small light or target inside the machine. The scan itself uses low-intensity laser light and is completely non-invasive. You will not feel anything touching your eye. Most scans take only a few minutes per eye.
The TruTrack system compensates for small eye movements. You can help improve image quality by keeping your gaze as steady as possible on the target. If you have trouble holding still, let the technician know. Brief breaks can be taken as needed.
There is no recovery time needed from the imaging itself. If your eyes were dilated, the blurriness and light sensitivity will gradually wear off over three to six hours. If dye was used for angiography, you may notice that your skin appears slightly yellow for a few hours. Your urine may be bright yellow or orange for a day. These effects are harmless and temporary.
Factors That Affect Image Quality
Research has shown that among 2,313 eye scans using the Spectralis, 46.3% had at least one artifact (JAMA Ophthalmology, 2015). Decentration error, where the scan is not perfectly centered, was the most common artifact at 27.8%. Posterior vitreous detachment artifacts accounted for 14.4% of cases. These artifacts do not mean the test failed. Your retina specialist is trained to recognize and account for them when interpreting results.
Certain eye conditions increase the likelihood of image artifacts. These include visual acuity less than 20/40, moderate to severe cataracts (clouding of the natural lens inside the eye), and advanced glaucoma. If you have any of these conditions, your retina specialist may take extra steps to optimize image quality or use additional imaging methods.
Your ability to hold your head still and maintain steady fixation on the target light plays a role in scan quality. Older patients and those with difficulty sitting upright for extended periods may face challenges. The recently FDA-cleared Spectralis Flex Module, approved in October 2024, addresses this. It allows imaging of patients in a lying-down position. This module is designed for both pediatric and adult patients who may not be able to sit at a standard imaging device.
There are several things you can do to help your retina specialist get the clearest images possible during your Spectralis scan.
- Follow all instructions about eye drops and dilation before your appointment.
- Try to keep both eyes open and blink naturally during the scan.
- Focus on the target light as steadily as you can.
- Let the technician know if you feel uncomfortable, need to cough, or need a moment to rest.
- Inform your retina specialist about any eye conditions such as cataracts or dry eye that might affect the scan.
Recent Advances in Spectralis Technology
In July 2024, the FDA cleared the Spectralis OCT Angiography Module with SHIFT technology. OCT angiography, or OCTA, creates detailed maps of blood flow in the retina without injected dye. The SHIFT technology provides a preset scan speed of 125 kHz. According to Heidelberg Engineering, this reduces image acquisition time by roughly half compared to prior scan speeds (Heidelberg Engineering, 2024). This means a faster, more comfortable experience for patients while still capturing high-quality vascular images.
In October 2024, the FDA cleared the Spectralis Flex Module. This module allows retina specialists to perform multi-modal imaging on patients who are lying down. It is especially valuable for pediatric patients, patients under anesthesia, and adults with physical limitations. The Flex Module brings the same imaging capabilities of the standard Spectralis to a wider range of clinical situations.
The High Magnification Module enables non-invasive visualization of retinal microstructures that were previously too small to see with standard imaging. This level of detail is useful for studying conditions at the cellular level. The Nsite Analytics Module provides analysis of neuronal and axonal structures. It offers insights into how retinal diseases may relate to neurological health. These modules continue to expand the diagnostic capabilities of the Spectralis platform.
When to See a Retina Specialist
If you have been diagnosed with a retinal condition such as macular degeneration, diabetic retinopathy, or retinal vein occlusion, your retina specialist will likely recommend regular Spectralis imaging. The frequency depends on your specific condition and treatment plan. Patients receiving anti-VEGF injections may have OCT scans at each visit to guide injection timing.
Certain symptoms require prompt evaluation by a retina specialist. A sudden increase in floaters, flashes of light, a curtain or shadow over your vision, or sudden vision loss in one eye are all considered emergencies. See a retina specialist or go to the emergency room immediately if you experience any of these symptoms. The Spectralis and other imaging tools can help your retina specialist quickly identify the cause and determine the best course of action.
Questions and Answers
The Spectralis scan itself is non-invasive and does not cause pain. You will not feel anything touching your eye. The device uses low-intensity laser light to capture images. If your eyes are dilated beforehand, you may experience temporary blurriness and light sensitivity from the dilation drops, but this is not caused by the scan.
The actual scanning process typically takes only a few minutes per eye. However, your total appointment time may be longer if your pupils need to be dilated or if angiography with injected dye is performed. In most cases, the imaging portion of your visit is one of the shorter parts of your retina appointment.
The Spectralis provides highly detailed images of the retina, but it does not replace a comprehensive eye examination. Your retina specialist will use the Spectralis images alongside other clinical findings, including a dilated eye exam, visual acuity testing, and your medical history. In some cases, additional tests such as visual field testing may still be needed.
Moderate to severe cataracts can reduce the clarity of Spectralis images and increase the likelihood of imaging artifacts. Your retina specialist is trained to interpret scans even when cataracts are present. In some cases, repeat scanning, alternative imaging settings, or cataract surgery may be recommended to improve image quality.
The frequency of imaging depends on your specific eye condition and treatment plan. Patients with active retinal diseases being treated with injections may have OCT imaging at every visit. This could be as often as every four to eight weeks. Patients with stable conditions may only need imaging every few months or once a year. Your retina specialist will recommend a schedule based on your individual needs.